Piazze Juan, Dillon Kathleen Comalli, Albana Cerekja
Ospedale di Ceprano/Osp. SS Trinità, Sora, (FR) Italy.
J Prenat Med. 2012 Apr;6(2):18-21.
to verify whether there are other than transitory effects of antenatal betamethasone (administered for fetal lung maturity [FLM] enhancement) on fetal heart rate (FHR) variability detected by computerized cardiotocography (cCTG) in cases where formerly steroid-treated fetuses reached term.
cCTG of one hundred sixty-four women (study group) exposed to antenatal betamethasone for risk of preterm delivery in third trimester period were compared to controls (pregnancies who presented risk of preterm labour in the same period of cases, although with no steroids administration). cCTG was performed weekly as of standard schedule when pregnancies reach term from 37-40 weeks' gestation for cases and controls.
regarding data concerning cCTG at term for cases and controls, no significant difference was found for FHR, Acc (accelerations) 10 min, and FM (fetal movements) between groups. LV (low variation)/min and LV/msec were absent in cCTG parameters of fetuses in the study group. Instead, for all weeks studied (37 to 40), cCTG parameters were higher for HV (high variation)/msec, STV(short term variation)/msec, and Acc 15 in cases with respect to controls.
interestingly, maternal corticosteroid administration may be related to higher fetal reactivity when fetuses exposed to steroid therapy reach term. Our observation may help in the interpretation of a "more reactive" CTG trace in babies whose mothers previously received steroid therapy for FLM enhancement.
验证在既往接受类固醇治疗的胎儿足月分娩的情况下,产前倍他米松(用于促进胎儿肺成熟[FLM])对计算机化心动图(cCTG)检测的胎儿心率(FHR)变异性是否存在短暂影响以外的其他影响。
将164名在孕晚期因早产风险而接受产前倍他米松治疗的妇女(研究组)的cCTG与对照组(同期有早产风险但未使用类固醇的孕妇)进行比较。对于研究组和对照组,当妊娠从妊娠37 - 40周足月时,按照标准时间表每周进行一次cCTG检查。
关于足月时研究组和对照组cCTG的数据,两组之间在FHR、10分钟内的加速(Acc)和胎儿运动(FM)方面未发现显著差异。研究组胎儿的cCTG参数中不存在每分钟低变异(LV)/分钟和每毫秒LV。相反,在所有研究周(37至40周),研究组病例的高变异(HV)/毫秒、短期变异(STV)/毫秒和15次加速的cCTG参数均高于对照组。
有趣的是,当接受类固醇治疗的胎儿足月时,母体使用皮质类固醇可能与胎儿更高的反应性有关。我们的观察结果可能有助于解释母亲先前因促进FLM而接受类固醇治疗的婴儿的“反应性更强”的CTG轨迹。